Karin Schelch

6PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 18, 2025
Small Cell Lung Cancer Classification: Unraveling Heterogeneity to Enable Personalized Treatments.

Kristiina Boettiger, Ildikó Kovács, Lilla Horvath

|Dec 14, 2025
Fibroblast growth factor signals drive the metastatic behavior in small cell lung cancer.

Büsra Ernhofer, Anna Solta, Julia Sinner

|Sep 04, 2025
Inhibition of YB-1 phosphorylation enhances cisplatin activity and disrupts cell division in pleural mesothelioma.

Karin Schelch, Nadine Maach, Muhammad Hashim

|Sep 19, 2023
Entinostat Enhances the Efficacy of Chemotherapy in Small Cell Lung Cancer Through S-phase Arrest and Decreased Base Excision Repair.

Anna Solta, Kristiina Boettiger, Ildikó Kovács

|Mar 15, 2023
Dual targeting of BCL-2 and MCL-1 in the presence of BAX breaks venetoclax resistance in human small cell lung cancer.

Zsuzsanna Valko, Zsolt Megyesfalvi, Anna Schwendenwein

|Nov 03, 2017
A link between the fibroblast growth factor axis and the miR-16 family reveals potential new treatment combinations in mesothelioma.

Karin Schelch, Michaela B Kirschner, Marissa Williams

Pageof 1

Frequent Collaborators

5 joint publications

Balazs Dome

4 joint publications

Michael Grusch

4 joint publications

Clemens Aigner

2 joint publications

Kristiina Boettiger